(Q79098458)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518019%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518019%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

3

Mohammad F Huque

Mohammad F. Huque

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518019%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14518019

16 March 2024

Ralph B. D'Agostino Sr.

2

object named as

Ralph B D'Agostino

Ralph B. D'Agostino

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518019%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14518019

16 March 2024

author name string

Abdul J. Sankoh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14518019

16 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14518019

16 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518019%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

30 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14518019

full work available at URL

16 March 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fsim.1557

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.1557

16 March 2024

1 reference

16 March 2024

published in

Statistics in Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518019%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518019%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518019%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

3133-3150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518019%20AND%20SRC:MED&resulttype=core&format=json

An improved Bonferroni procedure for multiple tests of significance

19 December 2019

cites work

1 reference

19 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/BIOMET/73.3.751

Controlling alpha in a clinical trial: the case for secondary endpoints

2

1 reference

A reviewer's perspective on multiple endpoint issues in clinical trials

16 March 2024

6

1 reference

A Simple Sequentially Rejective Multiple Test Procedure

16 March 2024

8

1 reference

A sharper Bonferroni procedure for multiple tests of significance

16 March 2024

9

1 reference

A stagewise rejective multiple test procedure based on a modified Bonferroni test

16 March 2024

10

1 reference

Testing the statistical certainty of a response to increasing doses of a drug

16 March 2024

12

1 reference

Some comments on frequently used multiple endpoint adjustment methods in clinical trials

16 March 2024

15

1 reference

On closed testing procedures with special reference to ordered analysis of variance

16 March 2024

16

1 reference

Procedures for comparing samples with multiple endpoints

16 March 2024

17

1 reference

The analysis of multiple endpoints in clinical trials

16 March 2024

19

1 reference

Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate

16 March 2024

21

1 reference

Closed testing procedures for group sequential clinical trials with multiple endpoints

16 March 2024

24

1 reference

Closed procedures are better and often admit a shortcut

16 March 2024

26

1 reference

Testing secondary hypotheses following sequential clinical trials

16 March 2024

29

1 reference

Secondary endpoints can be validly analyzed, even if the primary endpoint does not provide clear statistical significance

16 March 2024

30

1 reference

Alpha calculus in clinical trials: considerations and commentary for the new millennium

16 March 2024

31

1 reference

Secondary endpoints cannot be validly analyzed if the primary endpoint does not demonstrate clear statistical significance

16 March 2024

32

1 reference

End-point interpretation in clinical trials: the case for discipline

16 March 2024

34

1 reference

Carvedilol and the Food and Drug Administration (FDA) approval process: the FDA paradigm and reflections on hypothesis testing

16 March 2024

35

1 reference

16 March 2024

Identifiers

DOI

10.1002/SIM.1557

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518019%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference